Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study
- 31 March 1996
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 128 (3), 313-318
- https://doi.org/10.1016/s0022-3476(96)70273-1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosisThe Lancet, 1992
- Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgeryBritish Journal of Surgery, 1988
- Neonatal thrombotic disease: Prevention, diagnosis, and treatmentThe Journal of Pediatrics, 1988
- Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosisBritish Journal of Surgery, 1988
- Use of Heparin in Newborn InfantsSeminars in Thrombosis and Hemostasis, 1988
- Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative studyBritish Journal of Surgery, 1985
- Anticoagulant therapy by continuous heparinization in newborn and older infantsThe Journal of Pediatrics, 1982
- Management of major thromboembolic complications of umbilical artery cathetersJournal of Pediatric Surgery, 1981
- Neonatal thrombosisJournal of Pediatric Hematology/Oncology, 1979
- Isolation and characterization of oligosaccharides obtained from heparin by the action of heparinaseBiochemistry, 1972